News

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Moderna stock is indeed in the doldrums today, but this offers the opportunity to buy at a reasonable price, and, 10 years ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...
Moderna (NasdaqGS:MRNA) recently experienced significant index changes, with the company being added to the Russell Midcap and Midcap Value indexes, while being dropped from several others. Over the ...
Shares of the copper mining company advanced 2.5% after President Trump announced that [a 50% tariff was coming]( ...